+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Artificial Cornea & Corneal Implant Market by Product Type, Material Type, Application, End User, Distribution Channel, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612776
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Artificial Cornea & Corneal Implant Market grew from USD 593.13 million in 2024 to USD 672.44 million in 2025. It is expected to continue growing at a CAGR of 12.75%, reaching USD 1.21 billion by 2030.

Revolutionizing Vision: An Introduction to the Artificial Cornea Landscape

The quest to restore sight and enhance quality of life has driven remarkable advances in corneal replacement therapies. As scarcity of donor tissue and rising incidence of corneal disorders place pressure on traditional transplant methods, innovative artificial cornea and corneal implant solutions have emerged as viable alternatives. This introduction outlines the burgeoning need for engineered corneal substitutes and highlights the key technological breakthroughs redefining ophthalmic care.

By bridging clinical gaps with biosynthetic scaffolds, xenogeneic grafts, and fully synthetic constructs, stakeholders are reshaping the standard of care. These engineered solutions not only address immunogenic concerns but also offer customizable optical properties and scalable production potential. With demographic trends indicating a growing aging population and increased prevalence of ocular diseases, the artificial cornea market is poised for sustained growth. This section sets the stage for a detailed exploration of market drivers, challenges, and emerging opportunities that will inform stakeholder strategies in delivering next-generation vision restoration.

Emerging Technological and Clinical Shifts Reshaping Corneal Implants

In recent years, the corneal implant sector has experienced transformative shifts driven by converging clinical needs and technological innovations. Regenerative medicine techniques, especially tissue engineering approaches that leverage three-dimensional bioprinting and cell seeding, are enabling the fabrication of patient-specific corneal constructs with unprecedented precision. These advances are complemented by synthetic polymer developments that enhance scaffold durability and optical clarity, creating hybrid solutions that blend biological compatibility with engineered performance.

Simultaneously, nanotechnology has emerged as a critical enabler, providing surface modifications that promote cellular integration and inhibit microbial colonization. Such enhancements have reduced post-operative complications and improved long-term graft stability. The shift toward biosynthetic corneas, which integrate collagen-based matrices with tunable polymeric networks, has accelerated clinical adoption by offering consistent quality and reduced dependence on donor tissue.

Moreover, collaborative models between academic research institutes and commercial entities have streamlined regulatory pathways, facilitating faster clinical trials and market entry. Innovations in surgical instrumentation and implantation techniques are further refining outcomes, driving a new era of minimally invasive procedures. Taken together, these shifts are not only broadening therapeutic options but also redefining competitive dynamics, prompting established players and new entrants to recalibrate their strategies for a rapidly evolving landscape.

Analyzing the Ripple Effect of 2025 U.S. Tariff Adjustments

The scheduled adjustment of U.S. tariffs in 2025 presents both challenges and opportunities for the artificial cornea market. Increases on imported raw materials such as polymers and specialty collagen derivatives could elevate production costs, prompting manufacturers to reassess their supply chain strategies. Domestic sourcing initiatives and regional manufacturing hubs have gained traction as companies seek to mitigate tariff-related uncertainties and maintain price competitiveness.

At the same time, elevated import duties may accelerate strategic alliances between global suppliers and U.S.-based production partners, enabling technology transfer and local capacity expansion. Such collaborations can offset added cost pressures by leveraging shared resources and expertise. On the regulatory front, tariff-induced cost realignments may compel health systems and payers to re-evaluate reimbursement models, fostering dialogues around value-based pricing and long-term clinical benefits.

Importantly, the tariff landscape is catalyzing innovation in alternative material formulations. Companies are intensifying research into locally available biopolymers and next-generation synthetic composites that deliver equivalent performance at lower cost. This pivot not only addresses immediate pricing concerns but also supports broader goals of supply chain resilience and sustainability. Overall, the 2025 tariff adjustments are reshaping industry priorities, compelling stakeholders to adopt agile strategies and reinforce competitive differentiation.

Decoding Market Dynamics Through Comprehensive Segmentation Analysis

When examining the market through the lens of product type, allografts remain a cornerstone modality, with cryopreserved tissues favored for their extended shelf life and fresh grafts offering enhanced cell viability. In parallel, biosynthetic corneas built on collagen frameworks and synthetic polymer matrices are gaining ground by delivering consistent quality and reducing dependency on donor pools. Keratoprosthesis solutions cater to complex cases where integrated design implants provide structural reinforcement, while nonintegrated designs offer adaptability. Xenogeneic corneas sourced from bovine and porcine origins contribute to early-stage research and hold promise for scalable transplant options.

Exploring material types reveals collagen’s enduring prominence due to its natural compatibility and mechanical resilience. Decellularized tissue scaffolds are emerging as a lower-immunogenicity alternative, while hydrogel constructs enable customizable hydration profiles that mimic native corneal biomechanics. Pmma implants, renowned for their optical clarity and long-term stability, continue to serve niche applications. Each material class injects unique performance attributes into the market mix, driving differentiated product pipelines.

Application-driven analysis underscores a tripartite demand structure: cosmetic procedures target patients seeking aesthetic enhancements, optical interventions address refractive errors and vision restoration, and therapeutic engagements focus on disease management. This segmentation illustrates how diverse clinical needs shape product development priorities. End users range from ambulatory surgical centers that facilitate outpatient procedures to hospitals equipped for complex surgeries, while specialized ophthalmic clinics and research institutes spearhead both clinical care and investigational studies.

Distribution channels further influence market dynamics. Direct sales models foster strategic partnerships and tailored support, distributors expand geographic reach through established networks, and online platforms cater to emerging digital procurement behaviors. Technological stratification highlights the integration of nanotechnology for surface engineering, the evolution of synthetic polymers for scaffold customization, and the maturation of tissue engineering techniques, including three-dimensional bioprinting and cell seeding, which collectively herald a new standard for personalized corneal implants.

Regional Footprints and Growth Drivers Across Key Global Markets

In the Americas, high healthcare expenditure and robust reimbursement frameworks have propelled early adoption of advanced corneal implant technologies. Leading academic centers and specialized eye institutes in North America drive clinical trials and foster public-private partnerships that accelerate innovation. Latin American markets, characterized by heterogeneous access models, benefit from government-led vision care initiatives that aim to expand affordability and address backlog of unmet needs.

Europe, Middle East & Africa presents a multifaceted environment where regional regulatory harmonization efforts coexist with disparities in healthcare infrastructure. Western European countries lead in incorporating biosynthetic implants into clinical pathways, supported by strong research funding and patient advocacy groups. In contrast, certain Middle Eastern and African regions prioritize humanitarian aid programs, leveraging donated tissue and low-cost implant alternatives to bridge treatment gaps and improve ocular health outcomes.

Asia-Pacific is emerging as the fastest-growing region, driven by expanding healthcare budgets and increasing capacity of ambulatory surgical centers in East Asia, Southeast Asia, and Oceania. Rapid technological adoption in countries like China, Japan, and Australia is complemented by government initiatives to support domestic manufacturing. Additionally, India’s burgeoning ophthalmic sector benefits from a high volume of procedures and competitive cost structures, positioning the region as a dynamic hub for both clinical service delivery and research collaborations.

Leaders and Pioneers: Spotlight on Key Industry Players

Market leaders are distinguishing themselves through diversified portfolios and strategic alliances. One prominent organization has invested heavily in donor tissue processing and cryopreservation technologies, reinforcing its allograft segment. Another innovator has pioneered synthetic polymer scaffolds, securing patents that underpin its biosynthetic cornea offerings. A visionary startup that focuses on living xenogeneic scaffolds has attracted significant venture capital, advancing its preclinical pipeline. Meanwhile, a specialist firm dedicated to recombinant collagen frameworks has forged clinical partnerships to validate its hydrogel-based products. Finally, a biotechnology company emphasizing multi-modal tissue engineering has integrated three-dimensional bioprinting and cell seeding in its development roadmap.

These players collectively illustrate diverse go-to-market strategies. Some prioritize vertical integration to ensure control over raw materials and manufacturing, while others leverage collaborative networks to accelerate R&D and navigate regulatory pathways. Strategic mergers and acquisitions continue to reshape the competitive landscape, with larger organizations acquiring niche innovators to bolster technological depth. As the market matures, differentiation will hinge on demonstrable clinical outcomes, cost-effective manufacturing, and the ability to scale production without compromising quality.

Strategic Actions for Navigating a Competitive Corneal Implant Market

Industry leaders must prioritize agile innovation, investing in next-generation materials and tissue engineering platforms that offer distinct clinical advantages. Establishing flexible supply chains that integrate local and global sourcing can mitigate tariff impacts while ensuring consistent access to critical biomaterials. Collaborative alliances with academic institutions and contract research organizations will streamline product development and regulatory approval, allowing faster market entry and reduced development risk.

In tandem, engaging early with regulatory agencies to align on clinical endpoints and post-market surveillance strategies will foster smoother approval processes across jurisdictions. A patient-centric approach, incorporating real-world evidence and patient-reported outcomes, will strengthen value propositions for payers and healthcare providers. Digital tools, such as teleophthalmology platforms and AI-driven image analysis, can enhance patient screening and follow-up care, creating integrated service models that differentiate offerings.

To capture emerging market opportunities, organizations should evaluate underserved regions and invest in targeted market access programs. Leveraging online distribution channels alongside traditional direct sales and distributor networks can expand reach, particularly in remote or resource-constrained settings. Finally, a commitment to sustainable manufacturing and transparent supply chain practices will resonate with stakeholders increasingly focused on environmental and social governance, cementing long-term market leadership.

Rigorous Research Methodology Underpinning Our Analysis

This analysis integrates a rigorous research methodology, beginning with an extensive review of peer-reviewed literature, clinical trial registries, regulatory filings, and patent databases. Primary research included in-depth interviews with ophthalmic surgeons, biomaterials experts, regulatory authorities, and industry executives to capture emerging trends and validate secondary data. Market dynamics were triangulated by comparing insights from scientific publications with company reports, industry conferences, and healthcare database analytics.

Segmentation frameworks were applied to dissect market behavior across product types, materials, applications, end users, distribution channels, and technologies. Regional market assessments leveraged localized data sources, including national health ministry reports and reimbursement policy documents. Competitive landscapes were mapped using company financial disclosures, patent portfolios, and strategic announcements.

To ensure methodological integrity, data gaps were identified and addressed through targeted follow-up inquiries, while conflicting information was subjected to expert adjudication. The research process adhered to established guidelines for market intelligence, emphasizing transparency, reproducibility, and stakeholder relevance. This comprehensive approach underpins the robustness of the findings and supports actionable insights for decision-makers.

Concluding Insights and Future Outlook

The evolution of artificial cornea and corneal implant solutions underscores the interplay between clinical necessity and technological ingenuity. Key drivers such as donor tissue scarcity, advancements in biomaterials, and supportive regulatory environments continue to propel market innovation. At the same time, external factors like tariff realignments and shifting reimbursement paradigms demand adaptive strategies and resilient supply chains.

Stakeholders who embrace collaborative models, prioritize patient-centered outcomes, and invest in scalable manufacturing platforms are best positioned to capitalize on emerging opportunities. The convergence of nanotechnology, tissue engineering, and synthetic polymer science heralds a new generation of corneal replacements that promise improved safety, efficacy, and accessibility. As the market matures, strategic differentiation will depend on clinical validation, cost-effectiveness, and the ability to navigate complex global dynamics.

This executive summary offers a high-level perspective on the forces shaping the landscape, equipping decision-makers with the insights needed to formulate informed growth strategies. By synthesizing segmentation, regional, and competitive analyses, it lays the groundwork for deeper exploration of specific market segments and technological pathways.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Allograft
      • Cryopreserved
      • Fresh
    • Biosynthetic Cornea
      • Collagen Based
      • Synthetic Polymer Based
    • Keratoprosthesis
      • Integrated Design
      • Nonintegrated Design
    • Xenogeneic Cornea
      • Bovine
      • Porcine
  • Material Type
    • Collagen
    • Decellularized Tissue
    • Hydrogel
    • Pmma
  • Application
    • Cosmetic
    • Optical
    • Therapeutic
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Ophthalmic Clinics
    • Research Institutes
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Online
  • Technology
    • Nanotechnology
    • Synthetic Polymers
    • Tissue Engineering
      • 3D Bioprinting
      • Cell Seeding
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bausch + Lomb Incorporated
  • Mediphacos S.A.
  • AcuFocus, Inc.
  • ReVision Optics, Inc.
  • FCI Ophthalmics, Inc.
  • CorNeat Vision Ltd.
  • EyeYon Medical Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Cornea & Corneal Implant Market, by Product Type
8.1. Introduction
8.2. Allograft
8.2.1. Cryopreserved
8.2.2. Fresh
8.3. Biosynthetic Cornea
8.3.1. Collagen Based
8.3.2. Synthetic Polymer Based
8.4. Keratoprosthesis
8.4.1. Integrated Design
8.4.2. Nonintegrated Design
8.5. Xenogeneic Cornea
8.5.1. Bovine
8.5.2. Porcine
9. Artificial Cornea & Corneal Implant Market, by Material Type
9.1. Introduction
9.2. Collagen
9.3. Decellularized Tissue
9.4. Hydrogel
9.5. Pmma
10. Artificial Cornea & Corneal Implant Market, by Application
10.1. Introduction
10.2. Cosmetic
10.3. Optical
10.4. Therapeutic
11. Artificial Cornea & Corneal Implant Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Ophthalmic Clinics
11.5. Research Institutes
12. Artificial Cornea & Corneal Implant Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Artificial Cornea & Corneal Implant Market, by Technology
13.1. Introduction
13.2. Nanotechnology
13.3. Synthetic Polymers
13.4. Tissue Engineering
13.4.1. 3D Bioprinting
13.4.2. Cell Seeding
14. Americas Artificial Cornea & Corneal Implant Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Artificial Cornea & Corneal Implant Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Artificial Cornea & Corneal Implant Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bausch + Lomb Incorporated
17.3.2. Mediphacos S.A.
17.3.3. AcuFocus, Inc.
17.3.4. ReVision Optics, Inc.
17.3.5. FCI Ophthalmics, Inc.
17.3.6. CorNeat Vision Ltd.
17.3.7. EyeYon Medical Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY CRYOPRESERVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY FRESH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COLLAGEN BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY SYNTHETIC POLYMER BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY INTEGRATED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY NONINTEGRATED DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DECELLULARIZED TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PMMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COSMETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY OPTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY CELL SEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 74. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 75. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 76. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 77. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CANADA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 139. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 141. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 142. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 143. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 144. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 145. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 155. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. FRANCE ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 172. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 174. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 175. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 176. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 177. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 178. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. ITALY ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 183. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 185. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 186. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 187. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 188. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 189. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. SPAIN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 227. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 229. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 230. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 232. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. DENMARK ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 249. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 251. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 252. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 253. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 254. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. QATAR ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 260. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 262. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 263. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 264. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 265. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. FINLAND ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 271. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 282. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY ALLOGRAFT, 2018-2030 (USD MILLION)
TABLE 284. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY BIOSYNTHETIC CORNEA, 2018-2030 (USD MILLION)
TABLE 285. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY KERATOPROSTHESIS, 2018-2030 (USD MILLION)
TABLE 286. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY XENOGENEIC CORNEA, 2018-2030 (USD MILLION)
TABLE 287. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 288. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA ARTIFICIAL CORNEA & CORNEAL IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL,

Companies Mentioned

The companies profiled in this Artificial Cornea & Corneal Implant market report include:
  • Bausch + Lomb Incorporated
  • Mediphacos S.A.
  • AcuFocus, Inc.
  • ReVision Optics, Inc.
  • FCI Ophthalmics, Inc.
  • CorNeat Vision Ltd.
  • EyeYon Medical Ltd.

Methodology

Loading
LOADING...

Table Information